Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1989 1
1990 3
1991 6
1992 3
1993 5
1994 5
1995 6
1996 7
1997 2
1998 2
1999 4
2000 4
2001 3
2002 11
2003 5
2004 7
2005 19
2006 25
2007 20
2008 22
2009 26
2010 43
2011 47
2012 31
2013 34
2014 45
2015 46
2016 37
2017 39
2018 60
2019 55
2020 52
2021 50
2022 48
2023 59
2024 57
2025 58

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

846 results

Results by year

Filters applied: . Clear all
Page 1
Diabetic Retinopathy Preferred Practice Pattern®.
Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS. Flaxel CJ, et al. Among authors: lim ji. Ophthalmology. 2020 Jan;127(1):P66-P145. doi: 10.1016/j.ophtha.2019.09.025. Epub 2019 Sep 25. Ophthalmology. 2020. PMID: 31757498 No abstract available.
Age-Related Macular Degeneration Preferred Practice Pattern®.
Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS. Flaxel CJ, et al. Among authors: lim ji. Ophthalmology. 2020 Jan;127(1):P1-P65. doi: 10.1016/j.ophtha.2019.09.024. Epub 2019 Sep 25. Ophthalmology. 2020. PMID: 31757502 No abstract available.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Among authors: lim ji. Ophthalmology. 2024 Aug;131(8):914-926. doi: 10.1016/j.ophtha.2024.02.014. Epub 2024 Feb 19. Ophthalmology. 2024. PMID: 38382813 Free article. Clinical Trial.
Reply.
Adelman R, Bailey ST, Fawzi A, Flaxel CJ, Lim JI, Vemulakonda GA. Adelman R, et al. Among authors: lim ji. Ophthalmology. 2020 Aug;127(8):e60. doi: 10.1016/j.ophtha.2020.04.023. Ophthalmology. 2020. PMID: 32703397 No abstract available.
Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.
Agostini H, Abreu F, Baumal CR, Chang DS, G Csaky K, Demetriades AM, Kodjikian L, Lim JI, Margaron P, Monés JM, Peto T, Ricci F, Rüth M, Singh RP, Stoilov I, Swaminathan B, Willis JR, Westenskow PD. Agostini H, et al. Among authors: lim ji. Graefes Arch Clin Exp Ophthalmol. 2024 Nov;262(11):3437-3451. doi: 10.1007/s00417-024-06531-9. Epub 2024 Jun 7. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 38847896 Free PMC article. Review.
Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy.
Ipp E, Liljenquist D, Bode B, Shah VN, Silverstein S, Regillo CD, Lim JI, Sadda S, Domalpally A, Gray G, Bhaskaranand M, Ramachandra C, Solanki K; EyeArt Study Group. Ipp E, et al. Among authors: lim ji. JAMA Netw Open. 2021 Nov 1;4(11):e2134254. doi: 10.1001/jamanetworkopen.2021.34254. JAMA Netw Open. 2021. PMID: 34779843 Free PMC article. Clinical Trial.
Diabetic Retinopathy Preferred Practice Pattern®.
Lim JI, Kim SJ, Bailey ST, Kovach JL, Vemulakonda GA, Ying GS, Flaxel CJ; American Academy of Ophthalmology Preferred Practice Pattern Retina/Vitreous Committee. Lim JI, et al. Ophthalmology. 2025 Apr;132(4):P75-P162. doi: 10.1016/j.ophtha.2024.12.020. Epub 2025 Feb 7. Ophthalmology. 2025. PMID: 39918521 No abstract available.
846 results